![]() |
||
![]() |
||
![]() |
||
Conference Menu
概要
Novel Vaccines
Advances In Cancer Vaccines
Clinical Risk Management For Vaccines
住宿及旅遊
贊助/展出
海報發表
詢問
報名
Sponsoring Publications
Corporate Sponsor: |
Advances In Cancer Vaccines - 概要![]() The Advances in Cancer Vaccines主要鎖定在利用免疫系統來對抗癌症之生物療法。來自企業界、學術團體、政府部門之關鍵人士將針對仿人類單株抗體技術(Humanized monoclonal antibodies)、可溶解接受器(soluble receptor)、免疫抑制劑(immunorepressant)、腫瘤治療等具挑戰性領域之發展現況,進行發表。 來自世界各地之學者專家將癌治療分野之免疫療法(immunotherapeutic)現階段之挑戰及突破進行議論。
Opportunities and Challenges for Cancer VaccinesUna Ryan, Ph.D., President & CEO, AVANT Immunotherapeutics Inc.
Vaccine, Immunotherapy and the Immunological Constant or RejectionFrancesco M. Marincola, Ph.D., Chief, Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health
Dendritic Cell Tumor Fusions from the Bench to the BedsideDavid Avigan, M.D., Director, Hematological Malignancies/Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School
GVAX Immunotherapy for Prostate CancerKristen M. Hege, M.D., Vice President, Clinical Research and Development, Cell Genesys |
|
|
中文官方網站營運:Cambridge Healthtech Institute 代理商 日商環球訊息有限公司
|
||